With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...

UCB has shared promising results from a late-stage study of fenfluramine in patients with an ultra-rare form of epilepsy. The ...

Crouch most recently served as therapeutic lead, oncology and specialty medicine for international developed markets at ...

Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research ...

Using technology to make your exhibitions stand out in 2025. In today’s fast-paced experience economy, pharma companies can ...

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to applying GDPR principles at events and tradeshows. With... In today’s ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

The drug is now the first-ever therapy approved in the US for MAS in patients with Still's disease The US Food and Drug Administration (FDA) has approved Sobi’s Gamifant (emapalumab-lzsg) as the first ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be approved in combination with ...

Kidney Research UK, the leading charity dedicated to kidney health, has made a significant investment in Cognitant Group Ltd, ...

Pfizer’s Hympavzi, given as a once-weekly subcutaneous injection using a pre-filled pen, works by reducing the amount of TFPI ...

The first patient in the UK has been treated by the NHS with CSL Behring’s haemophilia B gene therapy Hemgenix (etranacogene ...